Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics
Cellular and Infection Microbiology
Published on
Journal: Frontiers in Cellular and Infection Microbiology [Category] COVID-19, MERS, SARS,
Journal: Frontiers in Cellular and Infection Microbiology [Category] COVID-19, MERS, SARS,
[키워드] acute respiratory syndrome
addition
antigen processing
Apoptosis
ARDS
Atherosclerosis
cathepsin
cathepsin L
Cathepsins
Cell
chronic inflammation
coronavirus
coronavirus disease
COVID-19
COVID-19 patients
cysteine protease
Cytokine storm
Deterioration
detrimental
diabetes
discomfort
disease
Diseases
drug
enzyme
etiology
expression
Extracellular matrix
host cells
host genetics
Immunological response
immunopathological
implicated
Infection
infections
inflammatory status
inhibiting
Invasion
involved
late stage
lung
lysosomal
MERS-CoV
Metastasis
multiple organ failure
other diseases
Pandemics
pathological condition
physiological
renal
respiratory
robust
SARS-CoV
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 spike protein
the disease
therapeutic target
treat
tumors
up-regulated
viral infection
[DOI] 10.3389/fcimb.2020.589505 PMC 바로가기 [Article Type] Cellular and Infection Microbiology
[DOI] 10.3389/fcimb.2020.589505 PMC 바로가기 [Article Type] Cellular and Infection Microbiology